In this segment, panelists discuss treatment with ponatinib and omacetaxine mepesuccinate for patients with chronic myeloid leukemia who do not respond to imatinib, dasatinib, and nilotinib.
For more from this discussion, visit [ Ссылка ]
![](https://i.ytimg.com/vi/gmVGkC5GLfE/maxresdefault.jpg)
In this segment, panelists discuss treatment with ponatinib and omacetaxine mepesuccinate for patients with chronic myeloid leukemia who do not respond to imatinib, dasatinib, and nilotinib.
For more from this discussion, visit [ Ссылка ]